Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 266

    1.

    Impact of diabetic nephropathy on pharmacodynamic and Pharmacokinetic properties of insulin in type 1 diabetic patients.

    Rave K, Heise T, Pfützner A, Heinemann L, Sawicki PT.

    Diabetes Care. 2001 May;24(5):886-90.PMID: 11347749 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Renal and metabolic effects of insulin lispro in type 2 diabetic subjects with overt nephropathy.

    Ruggenenti P, Flores C, Aros C, Ene-Iordache B, Trevisan R, Ottomano C, Remuzzi G.

    Diabetes Care. 2003 Feb;26(2):502-9.PMID: 12547889 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    The effect of the insulin analog lispro on nighttime blood glucose control in type 1 diabetic patients.

    Ahmed AB, Home PD.

    Diabetes Care. 1998 Jan;21(1):32-7.PMID: 9538967 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    A direct comparison of insulin aspart and insulin lispro in patients with type 1 diabetes.

    Plank J, Wutte A, Brunner G, Siebenhofer A, Semlitsch B, Sommer R, Hirschberger S, Pieber TR.

    Diabetes Care. 2002 Nov;25(11):2053-7.PMID: 12401756 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Effect of continuous subcutaneous insulin infusion with lispro on hepatic responsiveness to glucagon in type 1 diabetes.

    Launay B, Zinman B, Tildesley HD, Strack T, Chiasson JL.

    Diabetes Care. 1998 Oct;21(10):1627-31.PMID: 9773721 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Prandial glycaemia after a carbohydrate-rich meal in type I diabetic patients: using the rapid acting insulin analogue [Lys(B28), Pro(B29)] human insulin.

    Heinemann L, Heise T, Wahl LC, Trautmann ME, Ampudia J, Starke AA, Berger M.

    Diabet Med. 1996 Jul;13(7):625-9.PMID: 8840095 [PubMed - indexed for MEDLINE]Related articles

    7.

    Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients.

    Bruttomesso D, Pianta A, Mari A, Valerio A, Marescotti MC, Avogaro A, Tiengo A, Del Prato S.

    Diabetes. 1999 Jan;48(1):99-105.PMID: 9892228 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Insulin lispro in CSII: results of a double-blind crossover study.

    Zinman B, Tildesley H, Chiasson JL, Tsui E, Strack T.

    Diabetes. 1997 Mar;46(3):440-3. Erratum in: Diabetes 1997 Jul;46(7):1239. PMID: 9032100 [PubMed - indexed for MEDLINE]Related articles

    9.
    10.

    Pramlintide reduces postprandial glucose excursions when added to regular insulin or insulin lispro in subjects with type 1 diabetes: a dose-timing study.

    Weyer C, Gottlieb A, Kim DD, Lutz K, Schwartz S, Gutierrez M, Wang Y, Ruggles JA, Kolterman OG, Maggs DG.

    Diabetes Care. 2003 Nov;26(11):3074-9.PMID: 14578242 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Insulin aspart (B28 asp-insulin): a fast-acting analog of human insulin: absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects.

    Mudaliar SR, Lindberg FA, Joyce M, Beerdsen P, Strange P, Lin A, Henry RR.

    Diabetes Care. 1999 Sep;22(9):1501-6.PMID: 10480516 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Treatment with insulin lispro changes the insulin profile but does not affect the plasma concentrations of IGF-I and IGFBP-1 in type 1 diabetes.

    Hedman CA, Orre-Pettersson AC, Lindström T, Arnqvist HJ.

    Clin Endocrinol (Oxf). 2001 Jul;55(1):107-12.PMID: 11453959 [PubMed - indexed for MEDLINE]Related articles

    13.

    Preprandial combination of lispro and NPH insulin improves overall blood glucose control in type 1 diabetic patients: a multicenter randomized crossover trial.

    Annuzzi G, Del Prato S, Arcari R, Bellomo Damato A, Benzi L, Bruttomesso D, Calderini MC, Coscelli C, Fedele D, Galluzzo A, Giordano M, Giorgino R, Lapolla A, Orsini P, Pagano G, Santoro D, Riccardi G.

    Nutr Metab Cardiovasc Dis. 2001 Jun;11(3):168-75.PMID: 11590992 [PubMed - indexed for MEDLINE]Related articles

    14.

    A double-blind, randomized, dose-response study investigating the pharmacodynamic and pharmacokinetic properties of the long-acting insulin analog detemir.

    Plank J, Bodenlenz M, Sinner F, Magnes C, Görzer E, Regittnig W, Endahl LA, Draeger E, Zdravkovic M, Pieber TR.

    Diabetes Care. 2005 May;28(5):1107-12.PMID: 15855574 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Lispro or regular insulin for multiple injection therapy in adolescence. Differences in free insulin and glucose levels overnight.

    Mohn A, Matyka KA, Harris DA, Ross KM, Edge JA, Dunger DB.

    Diabetes Care. 1999 Jan;22(1):27-32.PMID: 10333899 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Dose-response relationship of an oral insulin spray in six patients with type 1 diabetes: a single-center, randomized, single-blind, 5-way crossover study.

    Cernea S, Kidron M, Wohlgelernter J, Raz I.

    Clin Ther. 2005 Oct;27(10):1562-70.PMID: 16330292 [PubMed - indexed for MEDLINE]Related articles

    17.

    Pharmacokinetics and pharmacodynamics of lispro-insulin in hemodialysis patients with diabetes mellitus.

    Czock D, Aisenpreis U, Rasche FM, Jehle PM.

    Int J Clin Pharmacol Ther. 2003 Oct;41(10):492-7.PMID: 14703957 [PubMed - indexed for MEDLINE]Related articles

    18.

    The action profile of lispro is not blunted by mixing in the syringe with NPH insulin.

    Joseph SE, Korzon-Burakowska A, Woodworth JR, Evans M, Hopkins D, Janes JM, Amiel SA.

    Diabetes Care. 1998 Dec;21(12):2098-102.PMID: 9839100 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Optimal administration of lispro insulin in hyperglycemic type 1 diabetes.

    Rassam AG, Zeise TM, Burge MR, Schade DS.

    Diabetes Care. 1999 Jan;22(1):133-6.PMID: 10333914 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Intramuscular versus subcutaneous injection of soluble and lispro insulin: comparison of metabolic effects in healthy subjects.

    Rave K, Heise T, Weyer C, Herrnberger J, Bender R, Hirschberger S, Heinemann L.

    Diabet Med. 1998 Sep;15(9):747-51.PMID: 9737803 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data